Iridoid compounds represent a large group of the cyclopentano[c]pyran monoterpenoids found in many plants. These compounds exhibit various antimicrobial, 1) antitumoral, 2) hemodynamic, 3) and anti-inflammatory 4-7) activities. Patrinia saniculaefolia HEMSLY (Valerianaceae) is endemic in Korea and the roots of the genus Patrinia have been used in Korean traditional medicine for treating various diseases including inflammation, edema, appendicitis and abscesses. 8) However, the underlying mechanisms accounting for its anti-inflammatory actions have not yet been elucidated. In an attempt to develop anti-inflammatory compounds from P. saniculaefolia, nardostachin, 9) a known iridoid compound, was isolated from the MeOH extract of P. saniculaefolia.
Inhibitory Effects of Nardostachin on Nitric Oxide, Prostaglandin E 2 , and Tumor Necrosis Factor-a a Production in Lipopolysaccharide Activated Macrophages
bated with nardostachin for 30 min before the addition of LPS (200 ng/ml) unless otherwise stated. TNF-a levels in the cell cultures supernatants were measured using a commercially available mouse cytokine ELISA kit according to the manufacture's instructions (Genzyme).
Assay of NO Synthesis Synthesis of NO was determined by assaying culture supernatants for nitrite, the stable reaction product NO with molecular oxygen. Briefly, 100 ml of culture supernatants was allowed to react with 100 ml of Griess reagent (1% sulfanilamide, 0.1% naphthyethylenediamine dihydrochrolide, and 2.5% phosphoric acid) at room temperature for 10 min. The optical density of the assay sample was measured spectrophotometically at 570 nm. Fresh culture medium served as the blank in all experiments. Nitrite concentration was calculated from a standard curve derived from the reaction of NaNO 2 under assay conditions. Determination of Prostaglandin E 2 (PGE 2 ) PGE 2 production was determined using an enzyme immunoassay kit (Cayman Chemical, Ann Arbor, MI, U.S.A.) according to manufacturer's instruction. Raw264.7 cells were preincubated with nardostachin for 30 min before the addition of LPS (200 ng/ml) unless otherwise stated. PGE 2 in the cell culture supernatants was isolated for further analysis by an enzyme immunoassay.
SDS-PAGE/Immunoblot Analysis Raw264.7 cells were plated in 6-well plates (1ϫ10 6 cells/well) and treated with LPS for 24 h. The cells were washed and scraped into cold phosphate-buffered saline (PBS) and centrifuged at 500ϫg at 4°C. The cell pellets were resuspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 5 mM ethylenediaminetetraacetic acid [EDTA], 150 mM NaCl, 0.5% Nonidet-40, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml aprotinin, 1 mg/ml pepstatin, and 1 mg/ml leupeptin) and centrifuged to yield whole-cell lysates. The proteins (20 mg) were separated by 8% reducing sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred in 20% methanol, 25 mM Tris, and 192 mM glycine to a nitrocellulose membrane (Schleicher and Schull, Dassel, Germany). The nitrocellulose membrane was then blocked by incubation in TTBS (25 mM Tris-HCl, 150 mM NaCl, and 0.2% Tween 20) containing 5% nonfat milk. Subsequently, the membrane was incubated with anti-iNOS antibody or anti-COX-2 antibody for 4 h, washed, and finally incubated for 1 h with a secondary antibody conjugated to horseradish peroxidase. The protein bands were visualized using an enhanced chemiluminesence (ECL) system (Amersham Corp., Newark, NJ, U.S.A.).
RESULTS

Effects of Nardostachin on NO Production in Raw264.7 Cells
Having established that LPS can induce NO production in Raw264.7 cells, a known NOS inhibitor, L-N w -nitroarginine methyl ester (L-NAME), was used to test the inhibition of NO production in the assay system. The results suggest that NO production was significantly inhibited by L-NAME in the LPS-stimulated cells (Fig. 1B) . Nardostachin needs to be dissolved in DMSO which showed neither cytotoxicity nor any significant effect on NO production at concentrations up to 0.1% (data not shown). The next experiments were designed to test the overall effects of nardostachin on NO production in Raw264.7 cells stimulated by LPS. As a result, nardostachin caused the dose-dependent inhibition of NO production. As observed in the dose response curves in Fig. 1A , the IC 50 value was 12.3 mM.
Effects of Nardostachin on PGE 2 Production in Raw264.7 Cells To determine whether or not nardostachin can inhibit PGE 2 production, the kinetics of PGE 2 production were examined in macrophages stimulated with LPS. Nardostachin caused a dose-dependent inhibition of PGE 2 production in LPS-stimulated Raw264.7 cells. This inhibition was not due to nardostachin toxicity in the concentration range of 0-15 mM, as determined by trypan blue exclusion and adherent cell protein determination. The IC 50 value was found to be 20 mM from the dose response curves shown in Fig. 2 .
Effects of Nardostachin on iNOS and COX-2 Protein Expression in Raw264.7 Cells The inhibitory effect of nardostachin on inducible NO production was examined to determine if it is a direct effect of the iNOS protein or if this 1376 Vol. 26, No. 10 inhibition is mediated by some other mechanism. LPS induced the Mr 130000 iNOS protein in the Raw264.7 cells in a dose-dependent manner over the concentration range 10-10000 ng/ml (data not shown). As shown in Fig. 3 , the iNOS protein was not detected in unstimulated Raw264.7 cells, whereas LPS (200 ng/ml) strongly induced the formation of detectable iNOS. The LPS induced iNOS protein expression was inhibited by nardostachin at the concentration of 12.5 mM. In addition, LPS also induced COX-2 protein with a Mr 72000 in Raw264.7 cells. As shown Fig. 3 , the COX-2 protein expression induced by LPS (200 ng/ml) was dramatically decreased when the cells were pretreated for 30 min with nardostachin (20 mM).
Inhibition of TNF-a a Production by Nardostachin In order to determine whether or not nardostachin can modulate LPS-stimulated proinflammatory cytokines such as TNF-a production, the cells were pretreated with various nardostachin concentrations for 30 min prior to LPS stimulation. The production of TNF-a by the unstimulated Raw264.7 cells was Ͻ15 pg/ml (nϭ3). Incubation of these cells with LPS (200 ng/ml) for 1 h caused a substantial increase in TNF-a production (1100Ϯ30 pg/ml; nϭ3). When Raw264.7 cells were stimulated with LPS in the presence of nardostachin (0-25 mM), a concentration-related inhibition of TNF-a production with respective IC 50 values of 16.2 mM was observed.
DISCUSSION
Recently, we isolated two new iridoids such as patridoid I and II as well as a known iridoid, narostachin from Patrinia saniculaefolia HEMSLY. 15) Our continuing efforts to develop anti-inflammatory agents from medicinal herbs led to isolation of nardostachin, which was demonstrated to inhibit the production of TNF-a, NO, and PGE 2 in LPS-stimulated Raw264.7 macrophages. Evidence have been provided that proinflammatory cytokines such as TNF-a, interleukin-1b (IL-1b) and interleukin-6 (IL-6) mediate the development of various inflammatory diseases. [16] [17] [18] [19] Recently, An et al. reported catalposide, a major iridoid glycoside isolated from the stem bark of Catalpa ovata G. DON (Bignoniaceae), strongly inhibited both the production of proinflammatory cytokines and NO production in Raw264.7 macrophages activated with LPS. 20, 21) Nardostachin was examined to determine if it could suppress either iNOS or COX-2 because of the highly relevant nature of these enzymes in many diseases. The results showed that nardostachin inhibited both iNOS and COX-2 protein expression in a similar way in LPS-stimulated Raw264.7 cells. The role of nardostachin in the relationship between the NO or TNF-a and PGE 2 products is currently unknown and currently under investigation. For macrophages and some other cells, such as mesangial cells, the modulation of PG synthesis by NO has been envisioned. [22] [23] [24] Furthermore, the NO donors were independently able to initiate gene expression of COX-2, suggesting that the NO produced by NOS directly interacts with COX-2 causing an increase in enzymatic activity. 25, 26) In conclusion, the anti-inflammatory activity of Patrinia saniculaefolia HEMSLY could be attributed at least in part to the inhibition of TNF-a production and iNOS and COX-2 expression. These results could also serve as additional rationale for the use of Patrinia saniculaefolia HEMSLY in inflammatory disorders. Furthermore, nardostachin might itself be a tool for distinguishing between the multiple pathways leading to the activation of various response genes. Fig. 3 . Inhibition of Expression of iNOS and COX-2 Protein by Nardostachin in Raw264.7 Cells Raw264.7 cells were preincubated with nardostachin for 30 min before the addition of LPS (200 ng/ml), after which the cells were incubated for 24 h with vehicle (Un), LPS (200 ng/ml), and the indicated concentration of nardostachin. Samples were processed by SDS-PAGE and transferred to a nitrocellulose filter. The immunoblot was then probed with anti-iNOS antibody or anti-COX-2 at a dilution 1 : 1000. Similar results were obtained from 3 independent experiments. Fig. 4 . Inhibition of TNF-a Production by Nardostachin in LPS-Stimulated Raw264.7 Cells
